NFKB1 and cancer: Experimental trials in some types of cancer have reported that drugs that suppress the biological effects of NF-κB, such as indomethacin and curcimin, enhance the radiosensitivity of cancer cells by accentuating radiotherapy-induced apoptosis (133, 139).